151 related articles for article (PubMed ID: 2786320)
21. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor.
Leloup G; Lemoine P; Carmeliet P; Vaes G
J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251
[TBL] [Abstract][Full Text] [Related]
22. The action of vitamin D metabolites (25 OHD3--12,5 (OH)2D3--24.25 (OH)2D3--25.26 (OH)2D3) on vitamin D deficient rats.
Queille ML; Miravet L; Bordier P; Redel J
Biomedicine; 1978; 28(4):237-42. PubMed ID: 737274
[No Abstract] [Full Text] [Related]
23. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
24. The biphasic effect of triiodothyronine compared to bone resorbing effect of PTH on bone modelling of mouse long bone in vitro.
Soskolne WA; Schwartz Z; Goldstein M; Ornoy A
Bone; 1990; 11(5):301-7. PubMed ID: 2252807
[TBL] [Abstract][Full Text] [Related]
25. [Role of 24,25-dihydroxycholecalciferol in bone mineralization under hypokinesia in the rat].
Sergeev IN; Blazheevich NV; Belakovskiĭ MS; Spirichev VB; Ushakov AS
Kosm Biol Aviakosm Med; 1982; 16(5):74-7. PubMed ID: 6983003
[TBL] [Abstract][Full Text] [Related]
26. The effects of insulin and glucose on bone modelling in vitro.
Schwartz Z; Ornoy A; Soskolne WA
Diabetes Res; 1986 Jul; 3(6):321-6. PubMed ID: 3530596
[TBL] [Abstract][Full Text] [Related]
27. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
Boyce RW; Weisbrode SE
Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
[TBL] [Abstract][Full Text] [Related]
28. Increased bone formation and decreased bone resorption in fetal mouse calvaria as a result of intermittent compressive force in vitro.
Klein-Nulend J; Veldhuijzen JP; de Jong M; Burger EH
Bone Miner; 1987 Sep; 2(6):441-8. PubMed ID: 3505768
[TBL] [Abstract][Full Text] [Related]
29. Transplacental effects of 1,25-dihydroxycholecalciferol and of 24,25-dihydroxycholecalciferol on the limb skeleton of fetuses and offspring rats.
Zusman I; Hirsh BE; Edelstein S; Ornoy A
Acta Anat (Basel); 1981; 111(4):343-51. PubMed ID: 6976671
[TBL] [Abstract][Full Text] [Related]
30. Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3.
Lindgren JU; Johnell O; DeLuca HF
Clin Orthop Relat Res; 1983 Dec; (181):264-8. PubMed ID: 6688979
[TBL] [Abstract][Full Text] [Related]
31. Regulation of alkaline phosphatase by 1,25-dihydroxyvitamin D3 and ascorbic acid in bone-derived cells.
Franceschi RT; Young J
J Bone Miner Res; 1990 Nov; 5(11):1157-67. PubMed ID: 1702922
[TBL] [Abstract][Full Text] [Related]
32. The development of fetal mice long bones in vitro: an assay of bone modeling.
Soskolne WA; Schwartz Z; Ornoy A
Bone; 1986; 7(1):41-8. PubMed ID: 3516184
[TBL] [Abstract][Full Text] [Related]
33. Effects of the calcium antagonist, diltiazem on in vitro and in vivo/in vitro bone resorption.
Ly SY; Rebut-Bonneton C; Miravet L
Horm Metab Res; 1985 Mar; 17(3):152-5. PubMed ID: 3838964
[TBL] [Abstract][Full Text] [Related]
34. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro.
Boyan BD; Schwartz Z; Carnes DL; Ramirez V
Endocrinology; 1988 Jun; 122(6):2851-60. PubMed ID: 2836176
[TBL] [Abstract][Full Text] [Related]
35. 1,25-Dihydroxyvitamin D3 stimulates avian and mammalian cartilage growth in vitro.
Burch WM; Lopez-Claros M; Uskokovic MR; Drezner MK
J Bone Miner Res; 1988 Feb; 3(1):87-91. PubMed ID: 3213605
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid and 1,25-dihydroxyvitamin D3 stimulate osteoclast formation by different mechanisms.
Scheven BA; Hamilton NJ
Bone; 1990; 11(1):53-9. PubMed ID: 2331432
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of the ionophore A23187 and vitamin D metabolites on 45Ca desaturation curves derived from bone cells: interaction of a calcium channel channel inhibitor diltiazem.
Ly SY; Rebut-Bonneton C
Horm Metab Res; 1988 Feb; 20(2):103-6. PubMed ID: 3131223
[TBL] [Abstract][Full Text] [Related]
38. 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation.
Beresford JN; Gallagher JA; Russell RG
Endocrinology; 1986 Oct; 119(4):1776-85. PubMed ID: 3489608
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
Finch JL; Brown AJ; Slatopolsky E
J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683
[TBL] [Abstract][Full Text] [Related]
40. Gender-related effects of vitamin D metabolites on cartilage and bone.
Ornoy A; Suissa M; Yaffe P; Boyan BD; Schwartz Z
Bone Miner; 1994 Dec; 27(3):235-47. PubMed ID: 7696889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
